So far a fair company but I fear constant change will be the new normal. - werkgeversreview Anonieme werknemer bij Merck

4,0
14 jan 2010
Anonieme werknemer
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

I have only been an employee with the new organization since coming over from Schering-Plough so my impressions are limited. They have been pretty good about communicating their intentions with the integration. I had previously worked for Merck so I've known the organization. Benefits appear to be on-par with most industry leaders. Management is competent and the leadership is fully aware prepared to meet the many challenges that face the industry and the company in the coming years.

Minpunten

One word, Process. It defines Merck and although process can be necessary it also stifles creativity and risk taking. The organization appears to be very cautious especially in the wake of the Vioxx and Vytorin/Zetia debacles. The company is massive with the combination (currently 100K employees). Corporate politics is already rearing its ugly head.

Ontdek andere reviews over Merck

5,0
30 jun 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Excellent company to work with.

Minpunten

No cons encountered so far

4,0
30 jun 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Minpunten

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Bekijk reviews op: Nuttig|Beoordeling|Datum|Alle